All In Biotech

Drug Trial Radar · NCT03287232

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD)

Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) - (Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone)

Last checked: Nov 20, 2026Latest source record: Apr 9, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 653 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

653

Actual

Start

Oct 16, 2017

Primary completion

Mar 8, 2019

Study completion Jul 22, 2019

Sponsor

Lead sponsor
EndoCeutics Inc.Industry
Sponsor type
Industry
First posted
Sep 19, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 40 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective is to confirm the efficacy of intravaginal prasterone (DHEA) on Hypoactive Sexual Desire Disorder (HSDD) in postmenopausal women.

Conditions

  • Hypoactive Sexual Desire Disorder

Interventions

  • Placebo Vaginal InsertDrug

    Daily administration of a placebo vaginal insert.

  • Prasterone 6.5 mg (0.50%) Vaginal InsertDrug

    Daily administration of a 6.5 mg (0.50%) prasterone vaginal insert.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Sexual desireTime frame: 28 weeks
  2. Distress from low sexual desireTime frame: 28 weeks

Locations

69 sites in 2 countries. Site status is shown where the registry gives one.

  • Endoceutics site # 106

    Huntsville, Alabama

  • Endoceutics site # 104

    Mobile, Alabama

  • Endoceutics site # 117

    Tucson, Arizona

  • Endoceutics site # 108

    Berkeley, California

  • Endoceutics site # 121

    Los Alamitos, California

  • Endoceutics site #128

    Los Angeles, California

  • Endoceutics site # 30

    San Diego, California

  • Endoceutics site # 17

    San Diego, California

  • Endoceutics site # 36

    Denver, Colorado

  • Endoceutics site # 52

    Denver, Colorado

  • Endoceutics site # 125

    New London, Connecticut

  • Endoceutics site # 7

    Washington D.C., District of Columbia

  • Endoceutics site # 95

    Bradenton, Florida

  • Endoceutics site # 120

    Coral Gables, Florida

  • Endoceutics site # 99

    Fort Myers, Florida

  • Endoceutics site # 26

    Jacksonville, Florida

  • Endoceutics site # 60

    Lake Worth, Florida

  • Endoceutics site #118

    Miami Lakes, Florida

  • Endoceutics site # 54

    North Miami, Florida

  • Endoceutics site # 92

    Oviedo, Florida

  • Endoceutics site # 105

    Sanford, Florida

  • Endoceutics site # 114

    St. Petersburg, Florida

  • Endoceutics site # 89

    West Palm Beach, Florida

  • Endoceutics site # 80

    West Palm Beach, Florida

  • Endoceutics site # 90

    West Palm Beach, Florida

  • Endoceutics site # 107

    Decatur, Georgia

  • Endoceutics site # 119

    Roswell, Georgia

  • Endoceutics site # 23

    Sandy Springs, Georgia

  • Endoceutics site # 91

    Savannah, Georgia

  • Endoceutics site # 111

    Wichita, Kansas

  • Endoceutics site # 55

    Wichita, Kansas

  • Endoceutics site # 88

    Lexington, Kentucky

  • Endoceutics site # 86

    Louisville, Kentucky

  • Endoceutics site # 103

    Boston, Massachusetts

  • Endoceutics site # 22

    Kalamazoo, Michigan

  • Endoceutics site # 123

    Portsmouth, New Hampshire

  • Endoceutics site # 101

    Berlin, New Jersey

  • Endoceutics site # 50

    Neptune City, New Jersey

  • Endoceutics site # 44

    New Brunswick, New Jersey

  • Endoceutics site # 81

    Plainsboro, New Jersey

Showing 40 of 69 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.